Predictors of serum vitamin D levels in African American and European American men in Chicago.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 3678722)

Published in Am J Mens Health on March 07, 2012

Authors

Adam B Murphy1, Brian Kelley, Yaw A Nyame, Iman K Martin, Demetria J Smith, Lauren Castaneda, Gregory J Zagaja, Courtney M P Hollowell, Rick A Kittles

Author Affiliations

1: Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. a-murphy2@md.northwestern.edu

Articles citing this

Vitamin D deficiency predicts prostate biopsy outcomes. Clin Cancer Res (2014) 1.65

Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence. Cancer Epidemiol Biomarkers Prev (2013) 0.96

Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease. Front Immunol (2015) 0.91

Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum Genet (2014) 0.88

Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer Causes Control (2014) 0.87

Vitamin D and melanoma incidence and mortality. Pigment Cell Melanoma Res (2012) 0.87

Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP. PLoS One (2015) 0.84

Fine-mapping of IL16 gene and prostate cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev (2012) 0.81

Race and BMI modify associations of calcium and vitamin D intake with prostate cancer. BMC Cancer (2017) 0.79

Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy. J Clin Oncol (2016) 0.79

Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans. Front Immunol (2016) 0.78

Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men. Nutrients (2016) 0.77

Patterns of Transcriptional Response to 1,25-Dihydroxyvitamin D3 and Bacterial Lipopolysaccharide in Primary Human Monocytes. G3 (Bethesda) (2016) 0.76

Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy? Prostate Cancer Prostatic Dis (2016) 0.75

Mapping Variation in Cellular and Transcriptional Response to 1,25-Dihydroxyvitamin D3 in Peripheral Blood Mononuclear Cells. PLoS One (2016) 0.75

Prostatic compensation of the vitamin D axis in African American men. JCI Insight (2017) 0.75

Articles cited by this

A data-based approach to diet questionnaire design and testing. Am J Epidemiol (1986) 12.68

High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc (2006) 8.78

Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr (2008) 7.61

Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr (2002) 7.34

Estimates of optimal vitamin D status. Osteoporos Int (2005) 7.13

Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr (1999) 6.64

Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet (1982) 6.40

Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr (2005) 6.32

Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int (1997) 5.82

Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab (2005) 5.64

A reduced dietary questionnaire: development and validation. Epidemiology (1990) 5.41

Redefining vitamin D insufficiency. Lancet (1998) 5.26

Vitamin D: A millenium perspective. J Cell Biochem (2003) 4.84

Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med (2004) 3.45

Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res (2005) 3.13

Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr (2003) 3.04

The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis (2005) 3.04

Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr (2004) 2.29

Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab (2000) 2.28

Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int (2000) 2.02

Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res (1990) 2.00

Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab (2003) 1.98

Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab (2007) 1.96

An evaluation of a food frequency questionnaire for assessing dietary intake of specific carotenoids and vitamin E among low-income black women. Am J Epidemiol (1991) 1.92

Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer (2005) 1.83

25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol (2009) 1.71

Low vitamin D status among obese adolescents: prevalence and response to treatment. J Adolesc Health (2011) 1.64

Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr (2008) 1.56

Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am J Clin Nutr (2004) 1.53

Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women. Bone (2006) 1.33

The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3. Cancer Res (1992) 1.28

Measurement of skin color: practical application and theoretical considerations. J Med Invest (1998) 1.18

Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int (2009) 1.08

Vitamin D status in United States war veterans. Endocr Pract (2008) 0.77

Articles by these authors

Control of confounding of genetic associations in stratified populations. Am J Hum Genet (2003) 7.99

Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet (2003) 4.67

Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variation. Hum Genomics (2005) 3.77

cis-Regulatory changes in Kit ligand expression and parallel evolution of pigmentation in sticklebacks and humans. Cell (2007) 3.72

The landscape of recombination in African Americans. Nature (2011) 3.06

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol (2006) 2.87

Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology (2013) 2.86

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70

Genetic evidence for the convergent evolution of light skin in Europeans and East Asians. Mol Biol Evol (2006) 2.54

Bicycle-related genitourinary injuries. Urology (2011) 2.35

Genetic ancestry and the search for personalized genetic histories. Nat Rev Genet (2004) 2.08

Identification of protein complexes by comparative analysis of yeast and bacterial protein interaction data. J Comput Biol (2005) 2.02

The 8818G allele of the agouti signaling protein (ASIP) gene is ancestral and is associated with darker skin color in African Americans. Hum Genet (2005) 1.97

Molecular shape and medicinal chemistry: a perspective. J Med Chem (2010) 1.91

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest (2013) 1.89

A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82

A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest (2006) 1.79

Vitamin D deficiency predicts prostate biopsy outcomes. Clin Cancer Res (2014) 1.65

Outcomes in geriatric genitourinary trauma. J Am Coll Surg (2011) 1.60

Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet (2011) 1.54

Human genetic diversity and the nonexistence of biological races. Hum Biol (2003) 1.53

Human genetic diversity and the nonexistence of biological races. 2003. Hum Biol (2009) 1.51

Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet (2011) 1.47

Is routine postoperative chest radiography needed after percutaneous nephrolithotomy? Urology (2011) 1.43

Allelic variation at alcohol metabolism genes ( ADH1B, ADH1C, ALDH2) and alcohol dependence in an American Indian population. Hum Genet (2003) 1.39

Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. Prostate (2010) 1.32

Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology (2010) 1.31

COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis (2004) 1.30

IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis (2007) 1.28

Markers that discriminate between European and African ancestry show limited variation within Africa. Hum Genet (2002) 1.27

Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS One (2012) 1.15

Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nat Genet (2003) 1.12

Results from a prostate cancer admixture mapping study in African-American men. Hum Genet (2009) 1.11

Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J Pharmacol Exp Ther (2004) 1.11

Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans. Pharmacogenomics (2012) 1.09

Clinical outcomes of nonoperative management in emphysematous urinary tract infections. Urology (2012) 1.09

Signaling pathways in human skeletal dysplasias. Annu Rev Genomics Hum Genet (2010) 1.09

Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans. Pharmacogenet Genomics (2015) 1.08

Novel single nucleotide polymorphism associations with colorectal cancer on chromosome 8q24 in African and European Americans. Carcinogenesis (2009) 1.08

African ancestry is associated with asthma risk in African Americans. PLoS One (2012) 1.07

Intermittent gastric outlet obstruction caused by a prolapsing antral gastric polyp. World J Gastrointest Oncol (2010) 1.06

Genotype-guided dosing of vitamin K antagonists. N Engl J Med (2014) 1.06

Adjusting for population structure in admixed populations. Genet Epidemiol (2002) 1.04

Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer (2008) 1.03

Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate (2010) 1.02

Collateral damage: heat transfer as a possible mechanism of optic nerve injury during neurosurgical intervention. Ophthal Plast Reconstr Surg (2012) 1.01

ICAM gene cluster SNPs and prostate cancer risk in African Americans. Hum Genet (2006) 0.99

8q24 risk alleles in West African and Caribbean men. Prostate (2012) 0.98

8q24 sequence variants in relation to prostate cancer risk among men of African descent: a case-control study. BMC Cancer (2010) 0.97

Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer (2014) 0.96

Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists. J Urol (2010) 0.95

Type 2 deiodinase and host responses of sepsis and acute lung injury. Am J Respir Cell Mol Biol (2011) 0.94

Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study. BMC Cancer (2009) 0.93

No association between variant DNA repair genes and prostate cancer risk among men of African descent. Prostate (2010) 0.92

The relationship between "race" and genetics in biomedical research. Curr Hypertens Rep (2007) 0.92

Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate (2008) 0.91

Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC). Prostate (2007) 0.91

Recurrent giant cell carcinoma of the bladder. J Urol (2002) 0.90

Mineral Oil-induced Sclerosing Lipogranuloma of the Penis. J Clin Aesthet Dermatol (2010) 0.90

Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans. PLoS One (2011) 0.89

Comparison of statistical methods for estimating genetic admixture in a lung cancer study of African Americans and Latinos. Am J Epidemiol (2008) 0.89

Clinical characteristics and surgical outcomes of penetrating external genital injuries. J Trauma Acute Care Surg (2013) 0.89

Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis (2012) 0.88

Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum Genet (2014) 0.88

Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer Causes Control (2014) 0.87

Smoking and prostate cancer in a multi-ethnic cohort. Prostate (2013) 0.87

Racial disparities in prostate cancer incidence, biochemical recurrence, and mortality. Prostate Cancer (2011) 0.87

Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry. Hum Genet (2010) 0.87

E-cadherin polymorphisms and haplotypes influence risk for prostate cancer. Prostate (2006) 0.86

Role of TGF-β in a mouse model of high turnover renal osteodystrophy. J Bone Miner Res (2014) 0.85

Race as a social construct in head and neck cancer outcomes. Otolaryngol Head Neck Surg (2011) 0.84

In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by antisense oligonucleotides. Ther Adv Urol (2011) 0.84

Genetic associations in the vitamin D receptor and colorectal cancer in African Americans and Caucasians. PLoS One (2011) 0.83

Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry. BMC Cancer (2014) 0.83

National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Res (2011) 0.82

Fine-mapping of IL16 gene and prostate cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev (2012) 0.81

EphB2 SNPs and sporadic prostate cancer risk in African American men. PLoS One (2011) 0.81

Effects of BCL-2 suppression by antisense oligonucleotides on additional regulators of apoptosis compensatory change in non-targeted protein expression. In Vivo (2011) 0.81

Primary central nervous system vasculitis presenting as spinal subdural hematoma. World Neurosurg (2011) 0.80

Y chromosome lineages in men of west African descent. PLoS One (2012) 0.80

Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases. J Urol (2012) 0.80

Brief smoking cessation intervention: a prospective trial in the urology setting. J Urol (2012) 0.80

Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR. Med Oncol (2011) 0.80

Increased expression of the androgen receptor with p300 and interleukin-6 coactivators compensate for oligonucleotide suppression of bcl-2: no increased CREB binding protein or interleukin-4 expression. Ther Adv Urol (2013) 0.79

Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR. Med Oncol (2009) 0.79

Bax expression remains unchanged following antisense treatment directed against BCL-2. Med Oncol (2010) 0.79

Bispecific oligonucleotides may induce interferon expression in LNCaP cells enhancing surface antigen expression: effect of intrastrand base pair complementarity. In Vivo (2011) 0.79

Implementation of a percutaneous core needle biopsy training program: results from the University of Michigan-Komfo Anokye Teaching Hospital breast cancer research partnership. Ann Surg Oncol (2010) 0.79

Breast cancer risk and genetic ancestry: a case-control study in Uruguay. BMC Womens Health (2015) 0.79

Race and insurance status are risk factors for orchiectomy due to testicular trauma. J Urol (2012) 0.79

Iatrogenic ureteral injury secondary to a thoracolumbar lateral revision instrumentation and fusion. Spine J (2009) 0.78

Distal ureteral replacement with tubularized porcine small intestine submucosa. Urology (2002) 0.75

Descriptive epidemiology of selected olfactory tumors. J Neurooncol (2010) 0.75

In LNCaP cells enhanced expression of both androgen receptor and costimulatory protein p300 compensate for antisense oligonucleotide suppression of bcl-2. Ther Adv Urol (2011) 0.75

Reply by the authors. Urology (2013) 0.75